PDF herunterladen
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(04): 44-45
DOI: 10.1055/s-0041-1733099
Case Report

Delayed Isolated Abdominal Wall Recurrence in a Case of Ovarian Dysgerminoma

Amita Maheshwari
Department of Medical Oncology and Gynaecologic Oncology, Tata Memorial Hospital Dr. E. Borges Parel, Mumbai-400 012, India
,
Sudeep Gupta
Department of Medical Oncology and Gynaecologic Oncology, Tata Memorial Hospital Dr. E. Borges Parel, Mumbai-400 012, India
,
Rekha Wuntkal
Department of Medical Oncology and Gynaecologic Oncology, Tata Memorial Hospital Dr. E. Borges Parel, Mumbai-400 012, India
,
Sumeet Gujral
Department of Medical Oncology and Gynaecologic Oncology, Tata Memorial Hospital Dr. E. Borges Parel, Mumbai-400 012, India
,
Samir Shah
Department of Medical Oncology and Gynaecologic Oncology, Tata Memorial Hospital Dr. E. Borges Parel, Mumbai-400 012, India
,
Hemant Tongaonkar
Department of Medical Oncology and Gynaecologic Oncology, Tata Memorial Hospital Dr. E. Borges Parel, Mumbai-400 012, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints


Publikationsverlauf

Artikel online veröffentlicht:
28. März 2022

© 2004. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Williams SD, Blessing JA, Hatch KD, Homesley HD. Chemotherapy of advanced dysgerminoma: Trials of the Gynecologic Oncology Group. J Clin Oncol 1991;9:1950-1955
  • 2 Brewer M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Whrton JT. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 1999;17:2670-2675.
  • 3 Dark GG, Bower M, Newlands ES, Paradinas F, Rustin GJS. Surveillance policy for stage 1 ovarian germ cell tumours. J Clin Oncol 1997;15:620-624.
  • 4 Zanetta G, Bonazzi C, Cantu MG, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumours. J Clin Oncol 2001;19:1015- 1020
  • 5 Segelov E, Campbell J, Ng M, et al. Cisplatin-based chemotherapy for ovarian germ cell malignancies. The Australian experience. J Clin Oncol 1994;12-378-384.